These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27418145)

  • 1. NETs: organ-related epigenetic derangements and potential clinical applications.
    Cives M; Simone V; Rizzo FM; Silvestris F
    Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications.
    McMurry HS; Rivero JD; Chen EY; Kardosh A; Lopez CD; Pegna GJ
    Curr Probl Cancer; 2024 Oct; 52():101131. PubMed ID: 39173542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine tumours: cracking the epigenetic code.
    Karpathakis A; Dibra H; Thirlwell C
    Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
    Gujarathi R; Abou Azar S; Tobias J; Polite BN; Setia N; Feinberg N; Appelbaum DE; Keutgen XM; Liao CY
    Endocr Relat Cancer; 2024 Nov; 31(11):. PubMed ID: 39093924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors.
    Yuan F; Shi M; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
    Int J Biol Sci; 2014; 10(9):957-65. PubMed ID: 25210493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
    Jiao Y; Shi C; Edil BH; de Wilde RF; Klimstra DS; Maitra A; Schulick RD; Tang LH; Wolfgang CL; Choti MA; Velculescu VE; Diaz LA; Vogelstein B; Kinzler KW; Hruban RH; Papadopoulos N
    Science; 2011 Mar; 331(6021):1199-203. PubMed ID: 21252315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context matters - Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas.
    Sun C; Estrella JS; Whitley EM; Chau GP; Lozano G; Wasylishen AR
    Dis Model Mech; 2022 Aug; 15(8):. PubMed ID: 35976056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours.
    Pipinikas CP; Dibra H; Karpathakis A; Feber A; Novelli M; Oukrif D; Fusai G; Valente R; Caplin M; Meyer T; Teschendorff A; Bell C; Morris TJ; Salomoni P; Luong TV; Davidson B; Beck S; Thirlwell C
    Endocr Relat Cancer; 2015 Jun; 22(3):L13-8. PubMed ID: 25900181
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors.
    Hackeng WM; Assi HA; Westerbeke FHM; Brosens LAA; Heaphy CM
    Surg Pathol Clin; 2022 Sep; 15(3):541-554. PubMed ID: 36049835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex.
    Geis C; Fendrich V; Rexin P; Di Fazio P; Bartsch DK; Ocker M; Quint K; Heverhagen AE
    J Surg Res; 2015 Apr; 194(2):388-393. PubMed ID: 25439321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
    Park JK; Paik WH; Lee K; Ryu JK; Lee SH; Kim YT
    Oncotarget; 2017 Jul; 8(30):49796-49806. PubMed ID: 28591701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Menin expression is an early event in pancreatic neuroendocrine tumorigenesis.
    Hackeng WM; Brosens LA; Poruk KE; Noë M; Hosoda W; Poling JS; Rizzo A; Campbell-Thompson M; Atkinson MA; Konukiewitz B; Klöppel G; Heaphy CM; Meeker AK; Wood LD
    Hum Pathol; 2016 Oct; 56():93-100. PubMed ID: 27342911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Luchini C; Lawlor RT; Bersani S; Vicentini C; Paolino G; Mattiolo P; Pea A; Cingarlini S; Milella M; Scarpa A
    Curr Oncol Rep; 2021 Jul; 23(9):106. PubMed ID: 34269919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors.
    Heaphy CM; Singhi AD
    Hum Pathol; 2022 Nov; 129():11-20. PubMed ID: 35872157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetics of neuroendocrine tumors.
    Öberg K
    Semin Oncol; 2013 Feb; 40(1):37-44. PubMed ID: 23391111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DAXX, ATRX, and MSI in PanNET and Their Metastases: Correlation with Histopathological Data and Prognosis.
    Gisder DM; Overheu O; Keller J; Nöpel-Dünnebacke S; Uhl W; Reinacher-Schick A; Tannapfel A; Tischoff I
    Pathobiology; 2023; 90(2):71-80. PubMed ID: 35691289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumor.
    Quevedo R; Spreafico A; Bruce J; Danesh A; El Ghamrasni S; Giesler A; Hanna Y; Have C; Li T; Yang SYC; Zhang T; Asa SL; Haibe-Kains B; Krzyzanowska M; Smith AC; Singh S; Siu LL; Pugh TJ
    Genome Med; 2020 Apr; 12(1):38. PubMed ID: 32345369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypo-methylation mediates chromosomal instability in pancreatic NET.
    Marinoni I; Wiederkeher A; Wiedmer T; Pantasis S; Di Domenico A; Frank R; Vassella E; Schmitt A; Perren A
    Endocr Relat Cancer; 2017 Mar; 24(3):137-146. PubMed ID: 28115389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer. New epigenetic drivers of cancers.
    Elsässer SJ; Allis CD; Lewis PW
    Science; 2011 Mar; 331(6021):1145-6. PubMed ID: 21385704
    [No Abstract]   [Full Text] [Related]  

  • 20. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.